Literature DB >> 20238057

Investigating the mechanism of disease in the RP10 form of retinitis pigmentosa.

Catherine J Spellicy1, Dong Xu, Garrett Cobb, Lizbeth Hedstrom, Sara J Bowne, Lori S Sullivan, Stephen P Daiger.   

Abstract

Retinitis pigmentosa (RP) is a disease characterized by its vast heterogeneity. Many genes are associated with RP, and the disease causing mutations identified in these genes are even more numerous. To date there are 15 genes that cause autosomal dominant RP (adRP) alone. The role of some of these genes, while complex and not completely understood, is somewhat intuitive in that they are involved in pathways such as phototransduction. However, the role of other genes in retinal disease is not as predictable due to their ubiquitous function and/or expression. One such gene is inosine monophosphate dehydrogenase 1 (IMPDH1) IMPDH1 is a gene involved in de novo purine synthesis and is ubiquitously expressed. IMPDH1 mutations account for 2% of all adRP cases and are a rare cause of Leiber Congenital Amaurosis. Despite its ubiquitous expression missense mutations in this gene cause only retinal degeneration. This paradox of tissue specific disease in the presence of ubiquitous expression has only recently begun to be explained. We have shown in a recent study that novel retinal isoforms of IMPDH1 exist and may account for the tissue specificity of disease. We have gone on to characterize these retinal isoforms both in our laboratory and in collaboration with Dr. Lizbeth Hedstrom's laboratory at Brandeis University (Waltham, MA) in order to understand more about them. We believe that through clarifying the mechanism of disease in RP10 we will be equipped to consider treatment options for this disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20238057      PMCID: PMC4113320          DOI: 10.1007/978-1-4419-1399-9_62

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  30 in total

1.  Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.

Authors:  Jugnu Jain; Susan J Almquist; Pamella J Ford; Dina Shlyakhter; Yongping Wang; Elmar Nimmesgern; Ursula A Germann
Journal:  Biochem Pharmacol       Date:  2004-02-15       Impact factor: 5.858

2.  Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo.

Authors:  Jeremy E McLean; Nobuko Hamaguchi; Peter Belenky; Sarah E Mortimer; Martin Stanton; Lizbeth Hedstrom
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

3.  The Gly56Arg mutation in NR2E3 accounts for 1-2% of autosomal dominant retinitis pigmentosa.

Authors:  Anisa I Gire; Lori S Sullivan; Sara J Bowne; David G Birch; Dianna Hughbanks-Wheaton; John R Heckenlively; Stephen P Daiger
Journal:  Mol Vis       Date:  2007-10-17       Impact factor: 2.367

4.  Two distinct cDNAs for human IMP dehydrogenase.

Authors:  Y Natsumeda; S Ohno; H Kawasaki; Y Konno; G Weber; K Suzuki
Journal:  J Biol Chem       Date:  1990-03-25       Impact factor: 5.157

5.  Epidemiology of retinitis pigmentosa in Denmark.

Authors:  Marianne Haim
Journal:  Acta Ophthalmol Scand Suppl       Date:  2002

6.  Identification of an IMPDH1 mutation in autosomal dominant retinitis pigmentosa (RP10) revealed following comparative microarray analysis of transcripts derived from retinas of wild-type and Rho(-/-) mice.

Authors:  Avril Kennan; Aileen Aherne; Arpad Palfi; Marian Humphries; Alex McKee; Alan Stitt; David A C Simpson; Karin Demtroder; Torben Orntoft; Carmen Ayuso; Paul F Kenna; G Jane Farrar; Pete Humphries
Journal:  Hum Mol Genet       Date:  2002-03-01       Impact factor: 6.150

7.  Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa.

Authors:  Sara J Bowne; Lori S Sullivan; Susan H Blanton; Constance L Cepko; Seth Blackshaw; David G Birch; Dianna Hughbanks-Wheaton; John R Heckenlively; Stephen P Daiger
Journal:  Hum Mol Genet       Date:  2002-03-01       Impact factor: 6.150

8.  Retinal isoforms of inosine 5'-monophosphate dehydrogenase type 1 are poor nucleic acid binding proteins.

Authors:  Dong Xu; Garrett Cobb; Catherine J Spellicy; Sara J Bowne; Stephen P Daiger; Lizbeth Hedstrom
Journal:  Arch Biochem Biophys       Date:  2008-02-14       Impact factor: 4.013

9.  IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNA.

Authors:  Sarah E Mortimer; Dong Xu; Dharia McGrew; Nobuko Hamaguchi; Hoong Chuin Lim; Sara J Bowne; Stephen P Daiger; Lizbeth Hedstrom
Journal:  J Biol Chem       Date:  2008-10-30       Impact factor: 5.157

10.  On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa.

Authors:  Aileen Aherne; Avril Kennan; Paul F Kenna; Niamh McNally; David G Lloyd; Ian L Alberts; Anna-Sophia Kiang; Marian M Humphries; Carmen Ayuso; Paul C Engel; Jing Jin Gu; Beverly S Mitchell; G Jane Farrar; Pete Humphries
Journal:  Hum Mol Genet       Date:  2004-03-15       Impact factor: 6.150

View more
  3 in total

1.  Monogenic variants in dystonia: an exome-wide sequencing study.

Authors:  Michael Zech; Robert Jech; Sylvia Boesch; Matej Škorvánek; Sandrina Weber; Matias Wagner; Chen Zhao; Angela Jochim; Ján Necpál; Yasemin Dincer; Katharina Vill; Felix Distelmaier; Malgorzata Stoklosa; Martin Krenn; Stephan Grunwald; Tobias Bock-Bierbaum; Anna Fečíková; Petra Havránková; Jan Roth; Iva Příhodová; Miriam Adamovičová; Olga Ulmanová; Karel Bechyně; Pavlína Danhofer; Branislav Veselý; Vladimír Haň; Petra Pavelekova; Zuzana Gdovinová; Tobias Mantel; Tobias Meindl; Alexandra Sitzberger; Sebastian Schröder; Astrid Blaschek; Timo Roser; Michaela V Bonfert; Edda Haberlandt; Barbara Plecko; Birgit Leineweber; Steffen Berweck; Thomas Herberhold; Berthold Langguth; Jana Švantnerová; Michal Minár; Gonzalo Alonso Ramos-Rivera; Monica H Wojcik; Sander Pajusalu; Katrin Õunap; Ulrich A Schatz; Laura Pölsler; Ivan Milenkovic; Franco Laccone; Veronika Pilshofer; Roberto Colombo; Steffi Patzer; Arcangela Iuso; Julia Vera; Monica Troncoso; Fang Fang; Holger Prokisch; Friederike Wilbert; Matthias Eckenweiler; Elisabeth Graf; Dominik S Westphal; Korbinian M Riedhammer; Theresa Brunet; Bader Alhaddad; Riccardo Berutti; Tim M Strom; Martin Hecht; Matthias Baumann; Marc Wolf; Aida Telegrafi; Richard E Person; Francisca Millan Zamora; Lindsay B Henderson; David Weise; Thomas Musacchio; Jens Volkmann; Anna Szuto; Jessica Becker; Kirsten Cremer; Thomas Sycha; Fritz Zimprich; Verena Kraus; Christine Makowski; Pedro Gonzalez-Alegre; Tanya M Bardakjian; Laurie J Ozelius; Annalisa Vetro; Renzo Guerrini; Esther Maier; Ingo Borggraefe; Alice Kuster; Saskia B Wortmann; Annette Hackenberg; Robert Steinfeld; Birgit Assmann; Christian Staufner; Thomas Opladen; Evžen Růžička; Ronald D Cohn; David Dyment; Wendy K Chung; Hartmut Engels; Andres Ceballos-Baumann; Rafal Ploski; Oliver Daumke; Bernhard Haslinger; Volker Mall; Konrad Oexle; Juliane Winkelmann
Journal:  Lancet Neurol       Date:  2020-11       Impact factor: 44.182

2.  The functional impact of the C/N-terminal extensions of the mouse retinal IMPDH1 isoforms: a kinetic evaluation.

Authors:  Behnaz Andashti; Razieh Yazdanparast; Ebrahim Barzegari; Hamid Galehdari
Journal:  Mol Cell Biochem       Date:  2019-12-14       Impact factor: 3.396

Review 3.  The Role of the U5 snRNP in Genetic Disorders and Cancer.

Authors:  Katherine A Wood; Megan A Eadsforth; William G Newman; Raymond T O'Keefe
Journal:  Front Genet       Date:  2021-01-28       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.